For miR-145 this could be explained by the discrepancy in promoter hypermethylation at different stages, as indicated by the lack of promoter hypermethylation in SW1116 cells and the presence of miR-145 methylation in several Dukes stage C/p53 mutant CRC cell lines [42]. The gene discussed is TP53; the disease is colorectal carcinoma.